Preimplantation Genetic Testing
Genetic Testing (PGT)
Ensuring the healthiest possible outcomes
Overview
Preimplantation Genetic Testing (PGT) allows us to screen embryos for chromosomal abnormalities and specific genetic conditions before transfer. This advanced technology helps select the healthiest embryos, increasing success rates and reducing the risk of genetic diseases and miscarriage.
Key Benefits
The Process
IVF Cycle
Complete standard IVF to create embryos.
Embryo Culture
Embryos develop for 5–6 days to blastocyst stage.
Biopsy
A few cells are carefully removed from each embryo's outer layer.
Genetic Analysis
Cells are analyzed in our genetics lab or sent to a specialized facility.
Results
Results typically available in 1–2 weeks, indicating which embryos are healthy.
Transfer
A genetically normal embryo is selected for transfer.
Is This Right For You?
This treatment may be recommended for:
- Women 35 and older
- Couples with history of miscarriage
- Known carriers of genetic conditions
- Previous IVF failure
- Family history of chromosomal problems
- Those wanting to reduce multiple pregnancy risk
Frequently Asked Questions
What's the difference between PGT-A and PGT-M?
PGT-A screens for chromosomal abnormalities (such as Down syndrome). PGT-M tests for specific inherited genetic conditions (such as cystic fibrosis).
Does testing damage the embryo?
The biopsy removes only a few cells from the outer layer that becomes the placenta, not the baby. Research shows no increased risk of birth defects.
Related Treatments
Ready to Start Your Journey?
Take the first step toward building your family. Schedule a consultation with our fertility experts today and discover your personalized path to parenthood.
New patients receive a complimentary 15-minute phone consultation